STK-001-DS-501 - An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK 001
The purpose of this research study is to look at a possible new therapy for Dravet syndrome, called STK-001. Dravet syndrome is a severe form of epilepsy (a brain disorder that causes seizures). This extension study is open for children and teenagers who completed the treatment and follow-up period of the main study (called the MONARCH Study). The main purpose of the MONARCH Study was to evaluate the safety of different doses of the study drug STK-001. During the MONARCH Study, your child received one of the doses of study drug that was being looked at, varying between 10 mg and 30 mg. In this extension study, your child will receive the same dose of study drug as they received in the main study or a dose that is recommended by the group of medical experts who are overseeing the safety of this study. The main purpose of this extension study is to look at how safe STK-001 (referred to from now on as the “study drug”) is when given every 4 months over a year. The study will also look at how well a person can tolerate receiving multiple doses of the study drug.
Stomach Cancer | NYU Langone Health
Perlmutter Cancer Center doctors use chemotherapy, targeted therapy, radiation, and surgery to treat people with all types of stomach cancer.
Stress Fractures | NYU Langone Health
Doctors at NYU Langone diagnose stress fractures in their early stages and provide comprehensive care to help you recover quickly.
Stress Reduction for Irritable Bowel Syndrome | NYU Langone Health
NYU Langone gastroenterologists may recommend stress reduction strategies to relieve the symptoms of irritable bowel syndrome, or IBS.
Stress, Trauma & Resilience Treatment Service | NYU Langone Health
The Stress, Trauma, and Resilience Service at NYU Langone’s Child Study Center helps children overcome traumatic experiences.
STRIDE: A Study of Patients with Lower Extremity Acute Limb Ischemia to Remove Thrombus with the Indigo Aspiration System
LE ALI (lower extremity acute limb ischemia) is a serious medical condition that occurs when you have a sudden loss of blood flow in the vessels of your leg(s) due to a blockage or clot in a blood vessel. The purpose of this study is to collect real-world data on the safety and performance of the Indigo Aspiration System when used in patients who have LE ALI. The Indigo Aspiration System is a medical device that has been cleared by the United States Food and Drug Administration (FDA) for removing blood clots from the blood vessels using continuous suction. The device is commercially available in the United States.
Stridor | NYU Langone Health
Otolaryngologists at NYU Langone’s Voice Center specialize in diagnosing and treating stridor.
Stridor in Children | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone use a physical exam, imaging tests, and laryngoscopy to diagnose stridor in children.
STRIKE-PE: A Prospective Multicenter Study of the IndigoTM Aspiration System Seeking to Evaluate the Long-Term Safety and Outcomes of Treating Pulmonary Embolism
This is a post-market, observational, prospective, multicenter study to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).
Stroke | NYU Langone Health
The specialists at NYU Langone’s Comprehensive Stroke Care Center diagnose stroke and provide rapid, effective treatment.